Europe/India/Near East USA Asia
Bachem AG Bachem Americas, Inc. Bachem Japan K.K.
Hauptstrasse 144 3132 Kashiwa Street AREA Shinagawa, 13F
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA Tokyo 108-0075 - Japan
Tel +41 58 595 2021 Tel +1 888 422 2436 Tel +81 3 4405 3141
Fax +41 58 595 2040 Tel +1 888 4BACHEM Email sales.jp@bachem.com
Email sales.ch@bachem.com Fax +1 310 539 9428  
  E-mail sales.us@bachem.com  

MANUFACTURING CAPABILITIES

Manufacturing Capabilities

Bachem is the world's sole peptide full service provider, comprising

  • 6 production sites located in the U.S. and in Europe
  • ISO 13485 certified manufacturing sites in Vista, U.S. and St. Helens, United Kingdom
  • Research level production on both continents
  • Full cGMP manufacturing and regulatory support both in the U.S. and in Europe
  • Capacity to produce from milligram amounts for preclinical work up to tons of active pharmaceutical ingredients (APIs)  
  • Manufacturing of key intermediates in ton quantities
  • Production of small molecule generics and New Chemical Entities (NCEs) in multiple tons
  • Production and release of finished dosage forms

Our cGMP production sites in Bubendorf (Switzerland), Vionnaz (Switzerland), Torrance (USA) and Vista (USA) are inspected and approved by the FDA and local authorities. Production is carried out under the responsibility of Bachem, and release of finished dosage forms is conducted in the facility at Weil am Rhein (Germany).

Bachem's manufacturing capabilities are designed to meet current and future customer needs with respect to synthetic strategy (i.e. solid phase peptide synthesis, solution phase peptide synthesis, hybrid strategies). Thanks to our multi-purpose equipment, we can accommodate a wide range of chemical reactions and are expert in the synthesis of complex organic compounds.



  • Protecting groups (i.e. Boc, Fmoc, and Z)
  • Purification strategy (i.e. preparative HPLC, conventional chromatography, ion exchange, size-exclusion chromatography, counter-current distribution)
  • Flexibility and upscaling (i.e. reactors up to 6'400 liters)
  • Special customer request (i.e. dedicated production lines)
  • Special equipment (i.e. electrolysis unit, high-pressure equipment, loop reactor)

Bachem offers the following services for finished dosage forms intended for clinical trials or commercial supply for its Active Pharmaceutical Ingredients (APIs):

  • Compatibility studies
  • Stability studies
  • Sterile filling and formulation development in cooperation with partners
  • Release of finished dosage forms

 

 

Bachem Manufacturing Video »here«